Back to search
FDAFDA · Food and drugs·Recall number Z-1909-2019

REVACLEAR 400 Dialyzer, Product Code 114746L Revaclear 300 and Revaclear 400 dialyzers are indicated for treatment of chronic and acute renal failure by hemodialysis.

Published July 10, 2019 · Recall initiated: May 31, 2019

Summary

FDA records medical device Class II recall Z-1909-2019, published July 10, 2019 and initiated May 31, 2019. Recalling firm: Baxter Healthcare Corporation; Status: Terminated; Reported quantity: 65403 units; Lot: UDI 07332414124076 Lot Numbers: C419205101 C419205201 C419205301. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

There is a potential presence of ruptured dialyzer fibers which may lead to a blood leak during treatment.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Baxter Healthcare Corporation
Distributor
US Nationwide Distribution and Internationally to: Canada and Bermuda.
Lot
UDI 07332414124076 Lot Numbers: C419205101 C419205201 C419205301
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was REVACLEAR 400 Dialyzer, Product Code 114746L Revaclear 300 and Revaclear 400 dialyzers are indicated for treatment of chronic and acute renal failure by hemodialysis. recalled?

Yes. FDA published recall Z-1909-2019 on July 10, 2019. Reported hazard: There is a potential presence of ruptured dialyzer fibers which may lead to a blood leak during treatment.

What should I do if I have this product?

Voluntary: Firm initiated · Letter